Venoruton

Medicinal product

(Invented) name

Venoruton

Active substance (s)

O-(beta-hidroksietil)-rutozidas

Strength

20 mg/g

Pharmaceutical form

gelis

Route (s) of administration

vartoti ant odos

Legal status for supply

Nereceptinis

Narrow therapeutic index (NTI)

ATC code (s)

C05CA01, Rutoside

Marketing authorisation holder

GlaxoSmithKline Consumer Healthcare (UK) Trading Limited, Jungtinė Karalystė

Date of authorisation

1995-10-04

Date of renewal

2009-01-23

Documents

Stage

Išregistruotas

Controlled?

Controlled substance type

Legal basis

10a

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

1 g gelio yra	1 g
O-(beta-hidroksietil)-rutozidas	20 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
8507	13219	1013219	tūbelė	40 g, N1		Nereceptinis	LT/1/95/1299/002	Netiekiama	-	-	No	-	-	Download

Stadijos